PowerGrid Infrastructure Investment Trust Regulatory Approval

Annual General Meeting

PowerGrid Infrastructure Investment Trust Annual General Meeting

PowerGrid Infrastructure Investment Trust held its Fifth Annual Meeting of Unitholders on July 28, 2026. The meeting discussed the adoption of annual financial statements and valuation reports.

Financial Results

PowerGrid Infrastructure Investment Trust Q1 FY27 Results: Net Profit ₹185.1 Cr, Down 3.0% YoY

PowerGrid Infrastructure Investment Trust reported revenue from operations of ₹311.4 Cr (-0.6% YoY) and net profit of ₹185.1 Cr (-3.0% YoY) for Q1 FY27.

Key figure

Net profit ₹185.1 Cr · -3.0% YoY

Business Update

PowerGrid Infrastructure Investment Trust Business Update

POWERGRID Infrastructure Investment Trust disclosed its unitholding pattern for Q June 2026, with sponsors holding 15% and public 85% of 90.99 crore units. The filing meets SEBI InvIT disclosure rules.

Management Change

PowerGrid Infrastructure Investment Trust Management Change

POWERGRID Unchahar Transmission Ltd appointed Smt. Anita Soren as Independent Director. The appointment, effective July 6, 2026, is for three years.

Annual General Meeting

PowerGrid Infrastructure Investment Trust Annual General Meeting

POWERGRID Infrastructure Investment Trust will hold its Fifth Annual Meeting on July 28, 2026. The meeting will consider audited financial statements and valuation reports for the year ended March 31, 2026.

Annual Report

PowerGrid Infrastructure Investment Trust Annual Report

POWERGRID Infrastructure Investment Trust filed its Annual Report for FY 2025-26. The report includes corporate overviews, statutory reports, and financial statements.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.